Genomic epidemiology of Chikungunya virus in Colombia reveals genetic variability of strains and multiple geographic introductions in outbreak, 2014
Chikungunya virus (CHIKV) is considered a public health problem due to its rapid spread and high morbidity. This study aimed to determine the genetic diversity and phylogenetic relationships of CHIKVs in Colombia. A descriptive and retrospective study was carried out using sera of patients infected...
- Autores:
-
Villero Wolf, Yeneiris Karina
Mattar Velilla, Ameth Salim
Puerta González, Andrés
Arrieta Bernate, Germán Javier
Muskus, Carlos
Hoyos Lopez, Richard Onalbi
Pinzón, Hernando
Peláez Carvajal, Dioselina
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2019
- Institución:
- Corporación Universitaria del Caribe - CECAR
- Repositorio:
- Repositorio Digital CECAR
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cecar.edu.co:cecar/10868
- Acceso en línea:
- https://repositorio.cecar.edu.co/handle/cecar/10868
- Palabra clave:
- Chikungunya virus
Morbidity
Public health problem d
- Rights
- openAccess
- License
- Derechos reservados - Corporación Universitaria de Caribe - CECAR
| Summary: | Chikungunya virus (CHIKV) is considered a public health problem due to its rapid spread and high morbidity. This study aimed to determine the genetic diversity and phylogenetic relationships of CHIKVs in Colombia. A descriptive and retrospective study was carried out using sera of patients infected with Chikungunya during the outbreak in Colombia. The whole genomes of CHIKV (n=16) were sequenced with an Illumina Hi-seq 2500 and were assembled using the Iterative Virus Assembler software. A Bayesian inference phylogenetic analysis was carried out with 157 strains of worldwide origin. The Colombian CHIKV sequences were grouped in the Asian genotype; however, three independent phylogenetic subclades were observed, probably the result of three separate introductions from Panama, Nicaragua, and St. Barts. Each subclade showed several different non-synonymous mutations (nsP2-A153V; nsp2-Y543H; nsp2-G720A; nsP3-L458P; Capside R78Q), that may have functional consequences for CHIKV biology and pathogenesis. These same mutations may affect the efficacy of potential CHIKV vaccines. |
|---|
